The NLRP3 inflammasome in age-related eye disease: Evidence-based connexin hemichannel therapeutics. Mugisho OO, Green CR. Exp Eye Res 2022;215:108911.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mugisho OO, Green CR. The NLRP3 inflammasome in age-related eye disease: Evidence-based connexin hemichannel therapeutics. Exp Eye Res 2022;215:108911.
PMID: 34958779